Product Information
ANTI-DIARRHEAL 2 MG CAPLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1299 per EA under NDC 00904772512. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 6, 2000.
Strength
2 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904772512
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075232FDA Approved
1/6/2000
On Market Since
2/24/2003
Pharmacological Classes
Price Statistics
The NADAC for ANTI-DIARRHEAL 2 MG CAPLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1299 per EA |
|---|---|
| All-time high | $0.1995 (May 10, 2023) |
| All-time low | $0.1021 (Oct 21, 2015) |
| 52-week high | $0.1465 |
| 52-week low | $0.1233 |
| Median price | $0.1204 |
| Average price | $0.1266 |
| Largest weekly change | +26.8% (Sep 20, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loperamide Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANTI-DIARRHEAL 2 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for ANTI-DIARRHEAL 2 MG CAPLET, manufactured by Major Pharmaceuticals, is $0.1299 per EA (NDC 00904772512), effective Sep 30, 2026.
How has the price of ANTI-DIARRHEAL 2 MG CAPLET changed over time?
Over the history we have for it, the NADAC for ANTI-DIARRHEAL 2 MG CAPLET has risen 20.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ANTI-DIARRHEAL 2 MG CAPLET?
Since Nov 28, 2013, the NADAC for ANTI-DIARRHEAL 2 MG CAPLET has ranged from a low of $0.1021 (Oct 21, 2015) to a high of $0.1995 (May 10, 2023), with a median of $0.1204 per EA.
Are there cheaper alternatives to ANTI-DIARRHEAL 2 MG CAPLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ANTI-DIARRHEAL 2 MG CAPLET, is $0.1204 per EA — about 7% below ANTI-DIARRHEAL 2 MG CAPLET.
Who manufactures ANTI-DIARRHEAL 2 MG CAPLET?
ANTI-DIARRHEAL 2 MG CAPLET (NDC 00904772512) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.